Champions Oncology Ownership | Who Owns Champions Oncology?


OverviewForecastRevenueFinancialsChartTranscripts

Champions Oncology Ownership Summary


Champions Oncology is owned by 11.48% institutional investors, 26.67% insiders, and 61.85% retail investors. Battery management is the largest institutional shareholder, holding 17.44% of CSBR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.70% of its assets in Champions Oncology shares.

CSBR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockChampions Oncology11.48%26.67%61.85%
SectorHealthcare Stocks 232.80%10.63%-143.43%
IndustryBiotech Stocks 379.48%10.37%-289.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Battery management2.42M17.44%$13.92M
Nea management company1.71M12.34%$9.85M
Vanguard group334.61K2.43%$2.31M
Tocqueville asset management319.67K2.30%$1.84M
Morgan stanley242.30K1.74%$1.39M
Renaissance145.54K1.05%$836.85K
Blackrock funding, inc. /de123.90K0.89%$712.42K
Blackrock116.07K0.85%$600.09K
Mink brook asset management111.34K0.80%$640.19K
Geode capital management77.18K0.56%$443.86K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Battery management2.42M3.27%$13.92M
Nea management company1.71M0.56%$9.85M
Mink brook asset management111.34K0.36%$640.19K
Tocqueville asset management319.67K0.03%$1.84M
Essex investment management18.25K0.02%$104.93K
Mesirow financial investment management15.80K0.00%$90.85K
Renaissance145.54K0.00%$836.85K
Acadian asset management21.32K0.00%$121.00K
Cambridge investment research advisors12.25K0.00%$70.00K
Hightower advisors35.16K0.00%$202.16K

Top Buyers

HolderShares% AssetsChange
Vanguard fiduciary trust32.99K-32.99K
Mink brook asset management111.34K0.36%31.03K
Morgan stanley242.30K0.00%12.64K
Susquehanna group, llp11.52K-11.52K
Mesirow financial investment management15.80K0.00%5.50K

Top Sellers

HolderShares% AssetsChange
Eam investors---79.99K
Goldman sachs group---48.41K
Hillsdale investment management---25.10K
Gsa capital partners llp---20.98K
Jane street group---17.67K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust32.99K-32.99K$189.70K
Susquehanna group, llp11.52K-11.52K$98.76K
Vanguard global advisers2.09K-2.09K$12.04K
Lazard asset management1.35K-1.35K$9.00K
Cassaday & co wealth management10.00-10.00$58.00

Sold Out

HolderChange
Wells fargo & company/mn-47.00
Advisor group-100.00
Ubs group-190.00
Tower research capital llc (trc)-501.00
Whittier trust-800.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202523-11.54%1,583,092-72.05%110.68%1042.86%6-33.33%
Sep 30, 202526-18.75%5,663,057-1.90%412.33%7-46.15%928.57%
Jun 30, 202532-11.11%5,772,831-2.44%412.25%13-35.00%716.67%
Mar 31, 20253638.46%5,917,3213.47%432.44%21110.00%6100.00%
Dec 31, 20242618.18%5,718,724-1.12%422.32%10-9.09%350.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF235.74K1.70%-
Vanguard Total Stock Mkt Idx Inv229.97K1.66%-
IMC US Ultra Micro Cap88.31K0.64%-
Vanguard Institutional Extnd Mkt Idx Tr63.02K0.45%-
Pleiades Small Cap Equity A44.16K0.32%44.16K
Fidelity Extended Market Index32.32K0.23%520.00
iShares Micro-Cap ETF22.70K0.16%-
Extended Equity Market Fund E12.81K0.09%-
Extended Equity Market Fund B12.81K0.09%-
Blackrock Extended Mkt Fund CF12.81K0.09%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 12, 2024Mendelson Daniel Newman-Buy$6.50K
Jan 11, 2024Mendelson Daniel Newman-Buy$12.54K
Jan 10, 2024Mendelson Daniel Newman-Buy$18.58K
Jan 09, 2024Mendelson Daniel Newman-Buy$18.75K
Jan 08, 2024Mendelson Daniel Newman-Buy$6.15K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q1--
2024 Q4--
2024 Q18-
2023 Q49-

CSBR Ownership FAQ


Who Owns Champions Oncology?

Champions Oncology shareholders are primarily institutional investors at 11.48%, followed by 26.67% insiders and 61.85% retail investors. The average institutional ownership in Champions Oncology's industry, Biotech Stocks , is 379.48%, which Champions Oncology falls below.

Who owns the most shares of Champions Oncology?

Champions Oncology’s largest shareholders are Battery management (2.42M shares, 17.44%), Nea management company (1.71M shares, 12.34%), and Vanguard group (334.6K shares, 2.43%). Together, they hold 32.21% of Champions Oncology’s total shares outstanding.

Does Blackrock own Champions Oncology?

Yes, BlackRock owns 0.85% of Champions Oncology, totaling 116.07K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 600.09K$. In the last quarter, BlackRock increased its holdings by 389 shares, a 0.34% change.

Who is Champions Oncology’s biggest shareholder by percentage of total assets invested?

Battery management is Champions Oncology’s biggest shareholder by percentage of total assets invested, with 3.27% of its assets in 2.42M Champions Oncology shares, valued at 13.92M$.

Who is the top mutual fund holder of Champions Oncology shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Champions Oncology shares, with 1.70% of its total shares outstanding invested in 235.74K Champions Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools